Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
N4 Pharma Plc Share News (N4P)
N4P Share
Price
N4P Share
News
N4P Share
Chat
N4P Share
Trades2
N4P
Live RNS
N4P Share
Charts
N4P Broker
Ratings
N4P Directors
Deals
N4P Financial
Diary
N4P
Fundamentals
N4P Short
Positions
N4P
Media
N4P Company
Research
N4P Company
Timeline
- There is currently no data for N4P
N4 Pharma Plc News
N4 Pharma picks up controlling interest in Nanogenics
(Sharecast News) - Pharmaceutical firm N4 Pharma announced the acquisition of a controlling interest in Nanogenics on Thursday.
N4 Pharma shares fall as places shares to fund Nanogenics stake buy
(Alliance News) - N4 Pharma PLC on Thursday said it bought a controlling interest in Nanogenics Ltd, a company with a lipid and peptide-based delivery...
N4 Pharma interim loss narrows slightly as business outreach ongoing
(Alliance News) - N4 Pharma PLC on Tuesday said its business outreach is ongoing as it continued to work on getting Nuvec, its delivery system for vac...
LONDON MARKET MIDDAY: Miners lift FTSE 100 as Fed meeting kicks off
(Alliance News) - Stock prices in London were largely higher at midday on Tuesday, with stimulus talks in China helping lift the mood, as attention tu...
N4 Pharma shares soar on further patent grant for Nuvec in US
(Alliance News) - N4 Pharma PLC on Tuesday saw its shares rise, as it celebrated a patent grant for Nuvec in the US.
AIM WINNERS & LOSERS: N4 Pharma shares jump on grant of US patent
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.
IN BRIEF: N4 Pharma expands Professor Yu partnership on grant award
N4 Pharma PLC - Derby, England-based pharmaceutical company focused on developing Nuvec, a delivery system for vaccines and cancer treatments - Says i...
TRADING UPDATES: Eckoh expects profit up; LXi REIT refinances facility
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Follow the stocks
